(Q40642209)

22 September 2017

Disease progression in amyotrophic lateral sclerosis: predictors of survival (English)

1 reference

amyotrophic lateral sclerosis

22 September 2017

0 references

author name string

Magnus T

1

1 reference

22 September 2017

Beck M

2

1 reference

22 September 2017

Giess R

3

1 reference

22 September 2017

Puls I

4

1 reference

22 September 2017

Naumann M

5

1 reference

22 September 2017

Toyka KV

6

1 reference

22 September 2017

1 May 2002

1 reference

22 September 2017

1 reference

22 September 2017

25

1 reference

22 September 2017

5

1 reference

22 September 2017

709-714

1 reference

Relationship of manual muscle testing to objective strength measurements

22 September 2017

1 reference

Guidelines for the use and performance of quantitative outcome measures in ALS clinical trials

21 January 2018

1 reference

Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials.

21 January 2018

1 reference

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

21 January 2018

1 reference

Muscle strength and functional capacity in 78-81-year-old men and women

21 January 2018

1 reference

Amyotrophic lateral sclerosis. A study of its presentation and prognosis.

21 January 2018

1 reference

Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

21 January 2018

1 reference

The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients

21 January 2018

1 reference

Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium.

21 January 2018

1 reference

The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III.

21 January 2018

1 reference

The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials.

21 January 2018

1 reference

Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors.

21 January 2018

1 reference

The natural history of amyotrophic lateral sclerosis.

21 January 2018

1 reference

Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy

21 January 2018

1 reference

Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region

21 January 2018

1 reference

Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management.

21 January 2018

1 reference

The numbers of limb motor neurons in the human lumbosacral cord throughout life

21 January 2018

1 reference

The size and strength of the quadriceps muscles of old and young men.

21 January 2018

1 reference

Mortality from Amyotrophic Lateral Sclerosis, Other Chronic Disorders, and Electric Shocks among Utility Workers

21 January 2018

1 reference

Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988

21 January 2018

1 reference

Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

21 January 2018

1 reference

Clinical trial in Duchenne dystrophy. I. The design of the protocol

21 January 2018

1 reference

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

21 January 2018

1 reference

Respiratory function deterioration is not time-linked with upper-limb onset in amyotrophic lateral sclerosis

21 January 2018

1 reference

Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.10090

1 reference

22 September 2017

1 reference